Clinical Trials Logo

Risk Reduction clinical trials

View clinical trials related to Risk Reduction.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06071351 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Motivational Interviewing Effect on Reducing Cardiovascular Disease Risk Factors

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

Aim: The aim of this study is to examine the effect of motivational interviewing-based training program on reducing cardiovascular disease risk factors in adults. Methods: In the first stage, individuals' CVD risk levels were determined. In the second stage, a 6-session motivational interview-based training program was applied to the intervention group with a medium CVD risk level (HearthSCORE score between 2 and 5 points). Brochures were distributed to the control group.

NCT ID: NCT05777863 Active, not recruiting - Aging Clinical Trials

The Effects of a Multidomain Lifestyle Intervention on Brain Functioning and Its Relation With Immunometabolic Markers in Ageing

HELI
Start date: May 10, 2022
Phase: N/A
Study type: Interventional

HELI is a multicenter, randomised controlled trial in two Dutch research centres (Donders Centre for Cognitive Neuroimaging, Nijmegen, and the department of Human Nutrition & Health at Wageningen University) among 104 older adults aged 60-75 years who are at risk for cognitive decline with an intervention duration of 26 weeks (roughly 6 months). Participants are randomized in a 1:1 ratio to a multidomain lifestyle intervention characterized by group-sessions and guidance (high-intensity intervention group) versus online access to general lifestyle-related health information in the form of biweekly leaflets (low-intensity intervention group).

NCT ID: NCT05708014 Active, not recruiting - HIV Infections Clinical Trials

Personalized Prevention for Couples: A 16-month Digital RCT

LuvHub
Start date: January 11, 2023
Phase: N/A
Study type: Interventional

This couples-based, digital health intervention project is serostatus neutral and seeks to determine efficacy for: a) use and adherence to evidence-based HIV/STI prevention-care strategies; b) creation and adherence to a tailored prevention-care plan; c) creation and adherence to a tailored sexual agreement; and d) improvements in other relationship dynamics among male couples who are in a relationship (defined as greater than 3 months or more).

NCT ID: NCT05645640 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Strategy for Cardiovascular Disease Prevention Through Tailored Health Management in Individuals With Elevated Risk

SMARTER
Start date: March 16, 2023
Phase: N/A
Study type: Interventional

The China PEACE SMARTER trial is a cluster ramdomized trial aiming to assess the effectiveness of village doctor-led tailored health management on risk reduction of high-risk individuals for cardiovascular disease.

NCT ID: NCT05611580 Active, not recruiting - Chronic Disease Clinical Trials

Rural Chronic Disease Risk Reduction

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

This study tests a web-based chronic disease risk reduction intervention among rural adults.

NCT ID: NCT05256199 Active, not recruiting - Cognitive Decline Clinical Trials

Dutch Multidomain Lifestyle Intervention in Older Adults at Risk of Cognitive Decline

FINGER-NL
Start date: February 24, 2022
Phase: N/A
Study type: Interventional

FINGER-NL is a multi-center, randomized, controlled, multidomain lifestyle intervention trial among 1,206 older adults at risk for cognitive decline with a duration of 24 months. Participants are randomized in a 1:1 ratio to a personalized multi-domain lifestyle intervention (high-intensity intervention group) versus online access to general lifestyle-related health information (low-intensity intervention group).

NCT ID: NCT04470921 Active, not recruiting - Ovarian Cancer Clinical Trials

STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands

STOPOVCA
Start date: January 1, 2019
Phase:
Study type: Observational

The aim of this study is to optimize implementation of the opportunistic salpingectomy throughout the Netherlands.

NCT ID: NCT03935464 Active, not recruiting - Risk Reduction Clinical Trials

Point-of-care Urine Monitoring of Adherence: Testing a Real-Time Urine Assay of Tenofovir in PrEP

PUMA
Start date: March 17, 2021
Phase: N/A
Study type: Interventional

Worldwide expansion of pre-exposure prophylaxis (PrEP) with oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) will be critical to ending the HIV epidemic. However, maintaining daily adherence to PrEP can be difficult and the accuracy of self-reported adherence is often limited by social desirability bias. Pharmacologic adherence monitoring (measuring drug levels in a biomatrix) has been critical to the interpretation of the PrEP trials, but testing usually requires expensive equipment and skilled personnel. We have recently developed a point-of-care (POC) immunoassay to measure tenofovir in urine, allowing real-time adherence monitoring for the first time. We now want to test the acceptability, feasibility and preliminary impact of monitoring adherence in real-time using this novel POC assay with adherence feedback provided to the patient with supportive messaging (versus standard of care adherence counseling).

NCT ID: NCT03912753 Active, not recruiting - Clinical trials for Human Immunodeficiency Virus

Building Mobile HIV Prevention and Mental Health Support in Low-resource Settings

Start date: May 20, 2019
Phase: N/A
Study type: Interventional

The purpose of this research study is to provide help and support for mental health and human immunodeficiency virus (HIV) risk reduction among Romanian gay and bisexual men. GBM will participate in this study using mobile device (phones, tablets, or laptops) and will complete several confidential surveys and 8 confidential one-hour sessions, either with a trained counselor via chat or by reading about health information. This study also involves testing for HIV, syphilis, chlamydia, and gonorrhea.

NCT ID: NCT03227809 Active, not recruiting - Substance Abuse Clinical Trials

First Years Away From Home: Letting Go and Staying Connected

FYAH:LGSC
Start date: April 1, 2017
Phase: N/A
Study type: Interventional

Alcohol abuse is the leading cause of death and serious injury among college students, and students also experience significant harms from other types of substance misuse and risk behaviors. The proposed project is a randomized controlled trials that will test the protective effects of Letting Go and Staying Connected, a handbook for parents of students who are transitioning for the first time from home to college, the time when students are at greatest risk. The handbook encourages parent skill development and good management of their student's new independence, providing a clear framework to guide them in parenting at this stage. Targeted outcomes include reduction of substance use and risk behaviors. The primary hypothesis is that students who are in one of the two handbook conditions with their parents will report lower substance use and risk behaviors in the two years after college entry.